Fiche centre
Emory University Hospital
Atlanta — United States
Essais liés9clinical trials
VilleAtlantalocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07174414
Essais cliniques associés
9| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| MRI Guided Focal Laser Interstitial Thermal Ablation | Cancer | Non applicable | NCT03634579 | MRI Guided Prostate Cancer Focal Laser Ablation | TERMINATED |
| FARAPULSE™ Pulsed Field Ablation System | Maladie coronarienne | Non applicable | NCT06735534 | ReMATCH — Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System | ACTIVE_NOT_RECRUITING |
| WATCHMAN FLX LAAC Device | Accident vasculaire cérébral | Non applicable | NCT04394546 | CHAMPION-AF Clinical Trial | ACTIVE_NOT_RECRUITING |
| SESAME Procedure | Maladie coronarienne | Non applicable | NCT07806149 | NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective Study Using Improvised Off-Label Devices | NOT_YET_RECRUITING |
| Cilostazol 100 mg Tablets | Accident vasculaire cérébral | Phase 3 | NCT07174414 | Clarity — Cilostazol for Prevention of Recurrent Stroke Trial | NOT_YET_RECRUITING |
| Levodopa | Parkinson | Phase 4 | NCT06234995 | Cortical Electrophysiology of Response Inhibition in Parkinson's Disease | RECRUITING |
| HyperQureTM Renal Denervation (RDN) System: | Hypertension | Non applicable | NCT06526858 | Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension | RECRUITING |
| temporally-interfering electric field stimulation | Épilepsie | Non applicable | NCT06716866 | EE-DES-TIEF — Temporally Interfering Electric Field Stimulation in the Treatment of Epilepsy | ENROLLING_BY_INVITATION |
| Activa™ PC and Percept™ PC Neurostimulation Systems | Épilepsie | NA | NCT03900468 | Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS) | TERMINATED |